CoreCap Advisors »

Lenz Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $140k 3.0k 46.58
2025-03-31 $976 38 25.71
2024-12-31 $2.9k 101 28.87

More positions owned by CoreCap Advisors

Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Technology Select Sector Spdr Fund Etf (XLK)
Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Nvidia Corporation Stock (NVDA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)
Invesco S&p 500 Equal Weight Etf Etf (RSP)

View all positions for CoreCap Advisors

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics